Skip to main content
logo
Pharmosa Biopharm Inc. (TPEX:6875)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
39.35
-0.25 (-0.63%)
Mar 24, 2026, 1:30 PM CST

Pharmosa Biopharm Cash Flow Statement

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-383.85-166.658.46-266.51-256.48
Depreciation & Amortization
31.4825.8123.3212.711.79
Other Amortization
----0.01
Loss (Gain) From Sale of Assets
-0.34---
Loss (Gain) on Equity Investments
0.9-1.95-5.5-3.93-0.66
Stock-Based Compensation
2.763.580.870.5915.04
Other Operating Activities
-3.64-7.73--0.02-0.02
Change in Accounts Receivable
2.64-3.37-1.180.03-0.14
Change in Inventory
4.93-2.83-21.91--
Change in Accounts Payable
7.460.090.59-2
Change in Unearned Revenue
-6.8911.71---
Change in Other Net Operating Assets
-13.2713.8426.81-1.19-9.05
Operating Cash Flow
-357.48-127.1631.45-258.31-237.51
Capital Expenditures
-118.7-165.27-81.46-10.16-3.06
Sale (Purchase) of Intangibles
-0.65-0.7-0.01-0.03-0.19
Investment in Securities
369-869---
Other Investing Activities
6.52-4.6-1.40.028
Investing Cash Flow
256.17-1,040-82.87-10.174.75
Short-Term Debt Repaid
-----61
Long-Term Debt Repaid
-17.99-21.16-14.22-15.9-26.34
Total Debt Repaid
-17.99-21.16-14.22-15.9-87.34
Net Debt Issued (Repaid)
-17.99-21.16-14.22-15.9-87.34
Issuance of Common Stock
1.1963.26367.18495.42367.02
Financing Cash Flow
-16.89942.11352.97479.52279.68
Foreign Exchange Rate Adjustments
-0.010.0100.01-
Net Cash Flow
-118.21-224.62301.55211.0546.93
Free Cash Flow
-476.18-292.43-50.01-268.47-240.57
Free Cash Flow Margin
-707.88%-174.51%-15.90%--
Free Cash Flow Per Share
-3.68-2.31-0.44-2.73-2.83
Cash Interest Paid
3.654.442.860.651.21
Cash Income Tax Paid
2.092.94---
Levered Free Cash Flow
-365.3-255.43-50.37-165.23-135.95
Unlevered Free Cash Flow
-363.99-253.92-48.59-164.83-135.19
Change in Working Capital
-5.1319.444.31-1.15-7.19
Source: S&P Global Market Intelligence. Standard template. Financial Sources.